Hearing · house
At What Cost: Oversight of How the IRA's Price Setting Scheme Means Fewer Cures for Patients
2023-09-20 · 18:00
Source status: Scheduled
Committee
Location
2123, Rayburn House Office Building
Video
Witnesses
John Czwaratacki
Founder, Survivors for Solutions
Dr. Steve Potts
Chair of the Drug Development Council, International Cancer Advocacy Network
John Crowley
Executive Chairman, Amicus Therapeutics, Inc.
Dr. Aaron Kesselheim
Professor of Medicine, Harvard Medical School
Documents
Witness documents
Source: https://api.congress.gov/v3/committee-meeting/118/house/116389